This report studies the global transfection reagents and equipment market from 2016 to 2021. This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.

The global transfection reagents and equipment market is segmented on the basis of product, method, application, end user, and region.

Based on product, the transfection reagents and equipment market is categorized into reagents and instruments. In 2016, the reagents segment is estimated to account for the largest share of the market. However, the instruments market is likely to grow at the highest CAGR during the forecast period.

On the basis of method, this market is segmented into biochemical, physical, and viral methods. In 2016, the biochemical method segment is expected to account for the largest share of the market, while the viral method segment is expected to grow at the highest CAGR during the forecast period. The biochemical method segment is further classified into calcium phosphate, lipofection DEAE-dextran, and dendrimer. Whereas, the physical method segment is further divided into electroporation, nucleofection, and others (gengun, sonoporation, magnetofection, and optoinjection).

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139141146

Based on application, the market is segmented into biomedical research, protein production, and therapeutic delivery. In 2016, the biomedical research segment is estimated to account for the largest share of the market.

Based on end user, the market is segmented into academic & research institutes and pharmaceutical & biotechnologies companies. In 2016, the academic & research institutes segment is excepted to account for the largest share of the market. However, the pharmaceutical & biotechnologies segment is projected to grow at the highest CAGR during the forecast period.

On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.

Over the years, the transfection reagents and equipment market has witnessed various technological advancements to meet the needs of researchers and biotechnology & pharmaceutical companies. These advancements have led to the development of high throughput large scale transfection instruments and reagents with greater efficiency. Advanced technologies result in efficient quantitative and qualitative transfection in varied types of cells, including the hard-to-transfect cell lines.

The key players in this market are continuously striving to gain larger shares and expand their existing product portfolios by agreements, collaborations, and partnerships. The overall market was dominated by Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands). Other players include Polyplus-transfection SA (France), Bio-Rad Laboratories Inc. (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte, Inc. (U.S.).

Read More@ 
https://www.marketsandmarkets.com/PressReleases/transfection-reagents-equipment.asp

Players operating in the transfection reagents and equipment market adopted strategies such as agreements, collaborations, and partnerships to strengthen their global presence. The key players that have adopted these strategies include MaxCyte, Inc. (U.S.), Polyplus-transfection SA (France), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), F. Hoffmann-La Roche ltd (Switzerland), and Thermo Fisher Scientific Inc. (U.S.)

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
[email protected]